Sacrosidase
Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme. It is available as an oral solution. Sucraid is approved by the U.S. Food and Drug Administration (FDA) for the therapy of the genetically determined sucrase deficiency that is part of the Congenital Sucrase-Isomaltase Deficiency (CSID). Sucraid assists in the breakdown of sugar/sucrose into simpler forms. Many uses for Sucraid include the relief of gastrointestinal symptoms that are associated with CSID.

Sucraid is dispensed as a clear solution, with a pale yellow tint, which has a sweet taste. Users must take with food and patients who take Sucraid can maintain a normal diet. Sucraid is packaged in two plastic bottles, each 118ml. A scoop to measure Sucraid is included within the package.
Q7397389
Sucraid
Concept
Q12140
medication
Concept
Q2138267
sucrase
Concept
Q8047
enzyme
Concept
Q204711
Food and Drug Administration
Concept
Q498826
Congenital Sucrase-Isomaltase Deficiency
Concept
Q7397389
Sacrosidase
Concept
instance of
instance of